Industry Insights
-
Where The FDA And EMA Stand On Digital Endpoints
8/22/2025
In part two of this series on digital endpoints, consultant Anita Burrell reviews the extent of their regulatory acceptance and discusses how to ensure data produced from digital technologies satisfies regulators.
-
The New Standard In Participant-Centric Trials
8/21/2025
Clinical technology must serve both scientific rigor and human experience—and Castor is positioning itself at the forefront of this participant-led future.
-
Navigating The eCOA Vendor Landscape In 2025
8/21/2025
This guide offers a clear-eyed perspective on the current eCOA landscape, providing sponsors with actionable guidance to make confident, informed vendor choices.
-
How AI Can Accelerate Clinical Trials' Probabilities Of Technical And Regulatory Success (PTRS)
8/21/2025
AI expert Kelly H. Zou, Ph.D., explores how the technology can drive R&D successes, including clinical trials.
-
Unmasking Baseline Inflation In Clinical Trials
8/20/2025
Baseline inflation poses a major threat to CNS trial integrity by constraining the measurable range of improvement and obscuring true treatment effects.
-
What Clinical Operations Should Know About Medical Affairs And MSLs
8/20/2025
Having spent years in medical affairs and leading MSL teams, William Soliman, Ph.D., BCMAS, explores how clinical operations and medical affairs thrive in collaboration or struggle in silos and offers tips for better partnerships.
-
Data-Driven Automated Payments: Built For How Trials Actually Run
8/18/2025
A closer look at how data-driven automated payments reduce site burden, improve speed and accuracy, and create a smoother experience without adding operational complexity.
-
Navigating The Biopharma Finance And Accounting Tech Landscape
8/18/2025
During clinical trials, the intricacies of financial management intensify, necessitating advanced ERP functionalities to handle clinical accruals, compliance, and reporting.
-
From Missing To Meaningful: Solving EHR Data Gaps
8/18/2025
When data is missing or delayed, it can slow down trial progress. Improving EHR data quality strengthens clinical research and ensures faster access to life-changing therapies for patients in need.
-
Audit Trails And Transparency: Changes In Clinical Data
8/18/2025
Audit trails are not only a regulatory necessity but a strategic tool to ensure data reliability and accelerate high-quality clinical research outcomes.